Mitsubishi Electric Announces Consolidated Financial Results for Fiscal 2026
Businesswire· 2026-04-28 14:50
Powered and protected by[Privacy] (https://www.akamai.com/privacy) Powered and protected by ...
Siili Solutions Plc, Business review, 1 January–31 March 2026 (unaudited)
Globenewswire· 2026-04-28 14:30AI 处理中...
Siili Solutions Plc, Business review, 1 January–31 March 2026 (unaudited) Revenue and profitability weakened - measures to improve profitability in a challenging market continue Siili Solutions Plc Stock Exchange Release 28 April 2026 at 9:30 am EEST JANUARY-MARCH 2026 We continued our strategic renewal as planned and strengthened the sales organisationWe strengthened our offering to meet current customer demand and launched the Managed AI serviceThe revenue for the first quarter was EUR 25.7 (29.9) million ...
Quadient and Solix Strengthen SaaS Communications Lifecycle with Expansion of Advanced Enterprise Archiving
Globenewswire· 2026-04-28 14:30
Paris Quadient (Euronext Paris: QDT), a global automation platform powering secure and sustainable business connections, announced today that together with its partner Solix Technologies, it is expanding the availability of Quadient Inspire Digital Vault, a secure cloud-native archiving and retrieval solution for storing, managing and retrieving high-volume customer communications and enterprise records. First successfully launched in Europe and APAC in September 2024, Inspire Digital Vault is now available ...
Focusing on the New Ecosystem of Intelligent Packaging Manufacturing | CYCJET Cordially Invites You to interpack 2026 in Germany
Globenewswire· 2026-04-28 14:24
行业背景与公司亮相 - 全球领先的包装行业展览会interpack 2026将于2026年5月7日至13日在德国杜塞尔多夫举行,该展会是洞察未来行业趋势的关键平台 [1][11] - CYCJET作为工业喷墨和激光打码领域的知名品牌,将在8B馆H17-3展位首次亮相,并推出全球经销商招募计划以拓展国际业务 [2][10] 公司核心能力与市场地位 - 公司拥有超过20年的行业经验,整合研发、制造和销售,持有包括CE、FDA、SGS在内的多项专利和认证 [3] - 业务覆盖全球超过100个国家,为食品、制药和电子等行业解决附着力、标签清晰度和可追溯性等挑战 [3][13] 展会展示的核心产品线 - 高速数码喷墨打印系统:支持高达2400 DPI的多行、大幅面打印和全彩输出,适用多种油墨和材料,并可配备视觉检测系统进行实时质量控制 [4][5] - 激光打印机系列:包括光纤、CO₂和UV型号,其中LU5T Mini UV激光打印机紧凑、经济高效、易于集成,满足多样化的包装和高速生产需求 [8] - B系列连续喷墨打印机:经济高效且用途广泛,支持OEM定制,帮助经销商以灵活的耗材建立自有品牌 [8] - 热转印套印机:适用于软包装,支持可变数据、快速任务切换、打印稳定、成本低,并支持OEM定制,服务于企业和全球经销商的生产与市场拓展需求 [9] 全球业务拓展战略 - 公司正式启动“全球合作伙伴成长计划”,在全球范围内招募经销商 [10] - 该计划为经销商提供有竞争力的产品、OEM定制、供应链支持、区域保护及培训,旨在助力其快速启动业务并实现稳定盈利 [10]
Banco Comercial Português, S.A. informs about Bank Millennium (Poland) preliminary unaudited results in Q1 2026
Globenewswire· 2026-04-28 14:21
Banco Comercial Português, S.A. informs about Bank Millennium (Poland) preliminary unaudited results in Q1 2026 Attachment 2026 04 28 Resultados Polónia_EN ...
Results of Updated Mineral Resource and Reserves; Increases Consolidated M&I to 731koz Au and Inferred Resource to 653koz Au
Globenewswire· 2026-04-28 14:00
Results of Updated Mineral Resource and Reserves; Increases Consolidated M&I to 731koz Au and Inferred Resource to 653koz Au Serabi Gold plc (“Serabi” or the “Company”) (AIM:SRB, TSX:SBI, OTCQX:SRBIF), the Brazilian focused gold mining and development company, is pleased to announce updated Mineral Reserve estimates and Mineral Resource estimates for its Palito Mine and updated Mineral Resource estimates for its Coringa Mine, prepared in accordance with the standard of CIM and Canadian National Instrument 4 ...
Scancell receives FDA Fast Track Designation for iSCIB1+ in advanced melanoma and provides data update from its SCOPE Phase 2 study
Globenewswire· 2026-04-28 14:00
核心观点 - 公司Scancell Holdings plc用于治疗晚期黑色素瘤的主要候选药物iSCIB1+获得了美国FDA的快速通道资格认定 这标志着该药物在解决未满足的医疗需求方面潜力获得认可 并有望加速其临床开发和监管审评进程 [1][2][3] 临床数据与疗效 - 在2期SCOPE试验中 iSCIB1+与ipilimumab和nivolumab联合治疗在目标人群中显示出强效且持久的疗效 20个月时的无进展生存率高达77% [1][2] - iSCIB1+联合疗法相比标准护理方案显示出显著优势 标准护理方案ipilimumab联合nivolumab在20个月时的PFS为43% iSCIB1+联合疗法带来了超过30个百分点的提升 [2] - 更多来自2期SCOPE研究的PFS数据和早期总生存期数据预计将在2027年上半年公布 [1][4] 临床开发计划 - 公司计划在2026年下半年启动针对晚期黑色素瘤的注册性3期临床试验 [1][2] - 即将启动的3期试验的目标人群与2期SCOPE试验第三队列一致 该队列代表了约80%的黑色素瘤患者 [9] 公司背景与产品线 - 公司是一家临床阶段生物技术公司 致力于开发现成的靶向主动免疫疗法 [6] - 其领先的DNA ImmunoBody平台产品iSCIB1+在2期黑色素瘤试验中 无论是作为单药还是与检查点疗法联合 均显示出安全、持久且具有临床意义的获益 [6] - 公司还拥有Moditope平台 其领先的肽免疫疗法Modi-1正在多种实体瘤中进行2期研究 [6] - 公司全资子公司GlyMab Therapeutics Ltd 拥有针对肿瘤特异性聚糖的高亲和力抗体早期管线 其中两个已授权给国际生物技术公司Genmab A/S进行开发 [6] 快速通道资格的影响 - 快速通道资格旨在加速针对严重疾病且可能优于现有疗法的药物的审评 使有效疗法能更快惠及患者 [3] - 该资格允许公司与FDA进行更频繁的沟通 以确保开发计划的一致性 增强开发的可预测性 并支持更高效的临床开发路径 [3] - 此外 快速通道资格还使药物有资格获得加速批准、优先审评和滚动审评 [3]
Elis: Disclosure of trading in own shares occured from April 20 to April 24, 2026
Globenewswire· 2026-04-28 14:00
Disclosure of trading in own shares occurred from April 20 to April 24, 2026 Puteaux, April 28, 2026 In accordance with the regulations on share buybacks, in particular Regulation (EU) 2016/1052, Elis hereby declares the purchases of its own shares made from April 20 to April 24, 2026 under the buyback program authorized by the 24th resolution of the General Shareholders' Meeting of May 22, 2025: Aggregated presentation: Issuer nameIssuer code(LEI) Transaction dateISIN CodeDaily total Volume (in number of s ...
Kalmar secured an order of electric empty container handlers from Lechman Terminais
Globenewswire· 2026-04-28 14:00
Kalmar electric empty container handler Kalmar secured an order of electric empty container handlers from Lechman Terminais. KALMAR CORPORATION, TRADE PRESS RELEASE, 28 APRIL 2026 AT 9.00 (EEST)Kalmar secured an order of electric empty container handlers from Lechman TerminaisKalmar has secured an order from long-term customer Lechman Terminais in Brazil for six Kalmar electric empty container handlers. The order was booked in Kalmar's Q2 2026 order intake with delivery scheduled for Q1 of 2027. The new ...
Notice on convening the annual general meeting of Aktsiaselts Ekspress Grupp
Globenewswire· 2026-04-28 14:00
Notice is hereby given that the Management Board of Aktsiaselts Ekspress Grupp (registry code 10004677, official address Narva mnt 13, 10151 Tallinn, „Ekspress Grupp“) convenes the annual general meeting of shareholders, which will be held on 1 June 2026 at 10:00 at the seat of Ekspress Grupp, in the city of Tallinn, Narva mnt 13, 4th floor. The registration of participants in the meeting will commence at 9:30 at the location of the meeting. The circle of shareholders entitled to attend the meeting will be ...